Aditxt stock.

Short interest for Aditxt gives investors a sense of the degree to which investors are betting on the decline of Aditxt's stock. Short interest data is updated every two weeks.

Aditxt stock. Things To Know About Aditxt stock.

Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...Aditxt (ADTX) disclosed in a filing on Friday a prospectus for a common stock offering of up to 2.06M shares by selling stockholders.ADTX shares down 2% aftermarket.FilingAs further consideration, Aditxt will grant to Stanford 37,500 shares of common stock in Aditxt. Aditxt agrees the shares are valued at US$2.00 and will provide Stanford with the capitalization table upon which the above calculation is made. Aditxt will issue 28.34% of all shares granted to Stanford pursuant to this Section 7.2 directly to and ...Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...Apr 20, 2023 · Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...

Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity …

Dec 4, 2023 · Aditxt Inc (NASDAQ: ADTX) has experienced a decline in its stock price by -14.36 compared to its previous closing price of 3.97. However, the company has seen a fall of -6.34% in its stock price over the last five trading days. InvestorPlace reported 2023-11-30 that Aditxt (NASDAQ: ADTX ) stock is rocketing higher on Thursday despite […] 151.32. A high-level overview of Aditxt, Inc. (ADTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years. The Series B warrants are exercisable at $11.25 per share.Summary of all time highs, changes and price drops for Aditxt; Historical stock prices; Current Share Price: US$3.63: 52 Week High: US$76.40: 52 Week Low: …

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity …

Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Aditxt has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%. Is Aditxt Stock Undervalued? The current Aditxt [ ADTX] share price is $9.05. The Score for ADTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.Certificate of Amendment to Certificate of Incorporation of Aditxt, Inc. (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on August 17, 2023) 08-17 - 2 views Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 08-17 - 2 viewsAditxt, Inc., , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the closing of its previously announced... | June 17, 2023Company profile page for Aditxt Inc including stock price, company news, press releases, executives, board members, and contact informationAditxt®, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding …Certain Common Stock of Aditxt, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2023. Jul. 23: CI Aditxt, Inc. announced that it has received $0.001 million in funding Jul. 10: CI Aditxt, Inc. announced that it has received $0.25 million in funding Jul. 02: CIDec 4, 2023 · Aditxt Inc (NASDAQ: ADTX) has experienced a decline in its stock price by -14.36 compared to its previous closing price of 3.97. However, the company has seen a fall of -6.34% in its stock price over the last five trading days. InvestorPlace reported 2023-11-30 that Aditxt (NASDAQ: ADTX ) stock is rocketing higher on Thursday despite […]

Aditxt Inc ( ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical score of 40 indicates that the stock has traded less bullishly over the last month than 60% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher ...Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...Complete Aditxt Inc. stock information by Barron's. View real-time ADTX stock price and news, along with industry-best analysis. As further consideration, Aditxt will grant to Stanford 37,500 shares of common stock in Aditxt. Aditxt agrees the shares are valued at US$2.00 and will provide Stanford with the capitalization table upon which the above calculation is made. Aditxt will issue 28.34% of all shares granted to Stanford pursuant to this Section 7.2 directly to and ...Frequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 LafayetteDiscover historical prices for ADTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Aditxt, Inc. stock was issued. Aug 31, 2023 · Aditxt Inc ( ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical score of 40 indicates that the stock has traded less bullishly over the last month than 60% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher ...

Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ...May 18, 2021. Shareholder Letter from Amro Albanna. STOCK QUOTE View All CHARTING View Full Chart

189,204 Yield ADTX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) Shares Sold Short 959 Change from Last 140.35% Percent of Float... Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... Nov 27, 2023 · Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic ... Stock Quote ChartingAditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or …The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to …Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …Certain Common Stock of Aditxt, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2023. Jul. 23: CI Aditxt, Inc. announced that it has received $0.001 million in funding Jul. 10: CI Aditxt, Inc. announced that it has received $0.25 million in funding Jul. 02: CI

Nov 27, 2023 · Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic ...

Get the latest Aditxt, Inc. (ADTX) stock news and headlines to help you in your trading and investing decisions.Aditxt Inc (NASDAQ: ADTX) has experienced a decline in its stock price by -14.36 compared to its previous closing price of 3.97. However, the company has seen a fall of -6.34% in its stock price over the last five trading days. InvestorPlace reported 2023-11-30 that Aditxt (NASDAQ: ADTX ) stock is rocketing higher on Thursday despite […]May 18, 2021. Shareholder Letter from Amro Albanna. STOCK QUOTE View All CHARTING View Full Chart Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ... CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 Provided by Business Wire Aug 17, 2023 8:12 PM UTCKey Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K. Aditxt Inc. stock performance at a glance. Check Aditxt Inc. ’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. On April 3, 2023, Aditxt subsidiary, Pearsanta, Inc. (“Pearsanta”) submitted a bid to acquire substantially all of Lucira Health Inc.’s (“Lucira”) assets, which included Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. At the bankruptcy auction, which was held on April 6, 2023, Pearsanta was chosen as the ...Dec 1, 2023 · According to 1 stock analyst, the 12-month stock price forecast for Aditxt stock is $61, which predicts an increase of 1,694.12%. On average, analysts rate Aditxt stock as a strong buy. Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Stock Price Close [ 3.97 ] (x) Shares Outstanding [ 0.4 ] (=) Market Capitalization [ 1.754 M ] The tables below summarizes the trend in Aditxt’s market cap over the last five years: Date

Stock Quote; SEC Filings; Corporate Governance; Frequently Asked Questions; Media Room. News; Media Coverage; Interviews; Press Releases; Contact Us17 thg 8, 2023 ... Aditxt®, Inc. (NASDAQ: ADTX) is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system ...Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... Aditxt's stock closed Friday at 87.49 cents per share. Pfizer's stock closed at $41.19. Amro Albanna, the co-founder, chairman and CEO of Richmond, Virginia-based Aditxt, contended that picking ...Instagram:https://instagram. half dollar coin 1964 valuesmr stock forecastdollar stocks to buy nowbest international brokerage account Aug 17, 2023 · Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ... slbstockhighest stock Aditxt Inc ( ADTX) is up 11.47% today. ADTX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on ADTX! ADTX stock …151.32. A high-level overview of Aditxt, Inc. (ADTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. cheapest way to get business email Discover historical prices for ADTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Aditxt, Inc. stock was issued. Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Nov 30, 2023 · The average price predicted for Aditxt Inc (ADTX) by analysts is $3.70, which is $0.03 above the current market price. The public float for ADTX is 0.19M, and at present, short sellers hold a 1.89% of that float. On November 30, 2023, the average trading volume of ADTX was 189.67K shares. ADTX) stock’s latest price […]